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Background: Schistosomiasis and other worm infections have been 
associated with growth and cognitive impairments; however, whether 
treatment reverses these effects is uncertain. Moreover, mechanisms 
linking these infections to cognition are not clear. We aimed to 
compare growth and cognitive benefits of intensive versus standard 
anthelminthic treatment in school-aged-children and explore 
processes that might be involved. We hypothesised that intensive 
treatment would have greater benefits than standard treatment. 
Methods: The study was nested within a cluster-randomised trial of 
either quarterly single-dose praziquantel of 40mg/kg to treat 
Schistosoma mansoni plus triple dose albendazole of 400mg (intensive 
treatment) to treat soil-transmitted worms including Ascaris 
lumbricoides, hookworm and Trichuris trichiura, or annual single-dose 
praziquantel 40mg/kg plus six-monthly single-dose albendazole 
400mg (standard treatment) conducted in the Koome islands in Lake 
Victoria, Uganda (ISRCTN47196031). Children aged 5-9 years (N=384) 
were assessed on primary outcomes (height, weight and eight 
measures of cognitive ability), worm infection, and proposed 
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mediators of worm effects (cytokines, iron status, physical activity) at 
one year (intensive n=85; standard n=64) and at two years (intensive 
n=158; standard n=128) of the intervention. Linear regression was 
used to examine intervention effects on height, weight and cognitive 
performance. Linear mixed effects models were used to study 
changes in growth and cognitive performance between the two arms 
across the two time-points. 
Results: Intensive treatment resulted in lower Schistosoma mansoni 
prevalence than standard treatment (at one year, 41% versus 70%; 
adjusted odds ratio (aOR)=0.24, 95% CI: 0.12, 0.49; at two years, 39% 
versus 69%; aOR=0.27; 95% CI: 0.16, 0.43) but there were no 
significant differences in growth and cognitive outcomes at either 
time-point. Worms and treatment showed no consistent association 
with the proposed mediators of worm effects. 
Conclusion: Reduction in worm burden may not improve growth and 
cognitive outcomes in high S. mansoni transmission settings. Possible 
implications are discussed.
Keywords 
growth, cognitive performance, anthelminthic treatment, 
praziquantel, albendazole, Schistosoma mansoni
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Introduction
Many of the world’s children still battle with disease, poverty 
and malnutrition which impact negatively on their devel-
opmental potential1. Parasitic worm infections affect about 
90 million children (the majority from sub-Saharan Africa)2 
in whom they have been associated with impaired growth 
and cognition3–10. Of all children living in Lake Victoria 
islands, 80% are infected with Schistosoma mansoni or soil 
transmitted worms11 and may therefore be at risk for growth 
and cognitive impairment.
However, findings of studies on worms and cognition lack 
consistency and are inconclusive with regard to which cognitive 
functions are affected. While some studies have reported 
impairment of different cognitive functions to be associated 
with worm infections, other studies have not found significant 
associations12. These discrepancies could be due to differences 
or flaws in study designs including unmeasured confound-
ing by, for example, education, socio-economic status, nutrition 
and health related factors (in observational studies), as well as 
short follow-up periods, and modest sample size12. Further-
more, it may be that worms affect a wide range of structurally, 
functionally, or developmentally related cognitive skills, and 
the divergence between study findings may partly be because 
different studies have examined different outcomes. Studies 
suggest that attention (identified as ability on Picture Search7); 
working memory (as measured by Verbal Fluency and Digit 
Span Forward4,7); inhibition (as measured by the Stroop task8); 
and general cognitive ability (processing speed)3,5 may be selec-
tively impaired. These cognitive functions represent high order 
skills or executive functions that govern lower level cogni-
tive processes13,14 and are critical for children’s behaviour and 
learning15–17. If worm infections cause impairment of these 
functions, this would have implications for children’s educational 
and employment potential and success in life.
There has been much advocacy for mass de-worming, often 
based on the assumption that this will improve growth, 
cognitive ability and school performance. However, this 
assumption is largely extrapolated from data from observa-
tional studies. There is potential confounding driven by asso-
ciations between worm infections and many other exposures; 
interventional studies are therefore key to determining specific 
effects of worm infections and the benefits of anthelminthic 
treatment. However, treatment trials to date have been inconclu-
sive regarding benefits for growth and cognitive outcomes12,18,19. 
Indeed, the debate on whether worms actually impair cogni-
tive function has become intense. This prompted a reanalysis 
of data from one of the previous trials which suggested that 
there had been over-reporting of treatment effects on academic 
performance in the original trial report19. Three Cochrane sys-
tematic reviews highlight the divergence in findings and that 
many studies have reported weak or no effects of deworming 
interventions on growth and cognitive function20–22. However, 
it is important to note that the Cochrane reviews focus on soil 
transmitted helminths and the majority of studies were rated as 
of poor or moderate quality.
The Entebbe Mother and Baby Study, one of the few ran-
domised trials of anthelminthic treatment conducted to date, did 
not find significant effects of childhood anthelminthic treat-
ment on cognitive functions23 but there was an unexpectedly 
low background prevalence of worms among the children in 
the trial. Similarly, treatment of maternal helminths during 
pregnancy had no effect on cognitive functions in their infants24 
although there were some observational associations between 
maternal worms and measures of cognitive ability at 15 months24. 
Thus, while it is plausible that worms and their treatment may 
influence growth and cognitive outcomes, this is yet to be 
established.
Mechanisms by which worms may affect cognitive function 
have been hypothesized. These include anaemia and malnu-
trition, as well as more specific pathways such as changes in 
host immune responses leading to increased levels of circulat-
ing cytokines such as tumour necrosis factor alpha (TNF-α), 
interleukin (IL)-6, and IL-1025–27. Both nutritional and immu-
nological pathways might impact negatively on availability of 
dopamine (a vital neurotransmitter), thereby interfering with 
cognitive processes. Additionally, these mediators are believed 
to cause malaise, which negatively affects the child’s ability 
to play and learn from their environment, and to perform on 
cognitive assessments. These pathways have, however, not 
yet been examined.
We therefore took the opportunity of a community-based, clus-
ter-randomised trial of intensive versus standard anthelminthic 
treatment, conducted in a high Schistosoma mansoni trans-
mission setting11, to investigate the impact of intensive versus 
standard anthelminthic treatment, particularly for schistoso-
miasis, on growth and cognitive outcomes. We also explored 
some of the pathways by which worms may impair cognition 
(Figure 1). We investigated associations of worm infection 
and their treatment with iron and inflammatory cytokines, 
and whether these parameters are in turn associated with the 
cognitive outcomes measured in this study. We aimed to test 
the hypothesis that intensive anthelminthic treatment reduces 
the prevalence of worms and improves child growth and cog-
nitive functioning more than standard treatment; and that 
these benefits are mediated by improvements in iron sta-




The study was approved by the Uganda Virus Research Insti-
tute Research and Ethics Committee (Ref: GC/127/13/12/12), 
Uganda National Council for Science and Technology (Ref: 
HS1534) and London School of Hygiene and Tropical 
Medicine. Written informed voluntary consent was obtained 
from parents or guardians for all children. Written informed 
assent was also obtained from children aged 8 years and above. 
Witnessed consent was conducted for parents or participants 
who were illiterate. Participating children received a small gift 
(a word-picture book) in appreciation for their participation.
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Figure 1. Mechanisms by which parasitic worm infections are hypothesised to affect cognitive function.
Trial registration
The main study (LaVIISWA) within which this sub-study 
was nested was registered with Current Controlled Trials 
(ISRCTN47196031) on 7th September 2012.
Design, setting and participants
This study was nested within the Lake Victoria Island Interven-
tion Study on Worms and Allergy-related diseases (LaVIISWA) 
utilising its cluster randomised design of intensive mass 
anthelminthic treatment versus standard mass treatment in 
the Koome islands11. Within LaVIISWA, 26 fishing villages 
(clusters) of the Koome islands were randomised to receive 
intensive treatment for schistosomiasis and other worms (detailed 
below), or standard treatment (current government policy) 
with 13 villages (clusters) in each arm. Intensive treatment 
comprised of quarterly single-dose praziquantel 40mg/kg to 
treat Schistosoma mansoni plus triple-dose albendazole 400mg 
to treat soil transmitted worms including Ascaris lumbricoides, 
hookworm and Trichuris trichiura. Standard treatment comprised 
of single-dose praziquantel 40mg/kg plus six-monthly single-
dose albendazole 400mg. The intervention was administered over 
a period of three years11.
Funding for this nested study was limited to measurements 
at one and two years of intervention, and was not available 
for measurements at baseline or at three years (the formal end 
of the trial). Children within the window of rapid develop-
ment and school entry (5–9 years) were enrolled into this nested 
study to investigate growth and cognitive effects of the inter-
vention. In each village (cluster), children in the eligible age-
group were identified from the treatment registers - this was 
a census that was updated at each treatment round within 
LaVIISWA, listing all households (with unique numbers) and 
all their occupants including children. We aimed to recruit 
24 children per village. In the villages where the number 
identified were more than 24, names were entered into an excel 
file from which a list of 24 children was randomly selected using 
the random number generator function. Using household num-
bers, and with the help of the Village Health Teams, the selected 
participants were traced to their residences and those found 
eligible and whose parents were willing to consent were 
recruited into the study. By the time this nested study received 
funding, 12 of the 26 villages had already completed one 
year of follow-up and had started receiving the treatment for 
year two of the intervention, therefore were ineligible for 
inclusion in the first round of assessments. This left 14 villages 
that were available for recruitment into the sub-study at this 
time point, including two villages where there were no children. 
Hence initial recruitment was effectively done in 12 villages 
(seven in intensive and five in standard). After the second year 
of treatment, all 26 villages (13 villages in each arm) includ-
ing those villages that could not be assessed at the first year 
were included in the assessments. In the villages that partici-
pated in the first year, the same participants were reassessed at 
the end of the second year. 
General procedures
The intervention: Participants in the standard arm received 
annual praziquantel 40mg/kg (estimated with a height pole 
for individuals measuring 94cm and above) plus six-monthly 
single-dose albendazole, whereas those in the intensive arm 
received quarterly praziquantel 40mg/kg (estimated with a 
height pole extended downward to 60cm for inclusion of 
younger children)11,28,29 plus albendazole 400mg for three days.
Measurements: At each time point (one year and two years), 
child’s anthropometry (height and weight), temperature and 
general physical condition were assessed and recorded. Height 
and weight were measured using a Seca stadiometer and Seca 
digital weight scale, respectively (Seca Medical Measuring 
systems and scales). For height, three readings were recorded 
and the closest two (with a difference not exceeding 0.4cm) 
were used to calculate the average which was used for 
analysis. Weight was recorded twice to the nearest 0.1 kg 
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and the average of the two recordings used for analysis. The 
stadiometer and weighing scale were calibrated daily using 
a standard ruler and weights, respectively. Temperature was 
taken from the axilla using digital thermometers. For participants 
with a temperature greater than 37.5°C, subsequent procedures 
were postponed until they were well.
A single stool sample was obtained from each participant and 
examined for worms using the Kato Katz method30 with two 
thick smears read by two different technicians. The stool 
samples were collected by three trained field workers. Partici-
pants were given containers the evening before and requested to 
put in a stool sample early in the morning. The samples were 
picked from them (participants) that morning and analysed 
by two laboratory technicians who were based on that particu-
lar village, hence there was no transportation involved between 
collection and analysis. Blood (venous) samples (4mls) 
were collected in EDTA tubes and examined for malaria and 
Mansonella parasitology, haemoglobin estimation, cytokine 
levels, and iron profiles.
Laboratory tests were done according to standard operating 
procedures and ISO standards. Quality control was done for 
the various tests: 10% of stool slides were randomly selected 
and read again by a different technician in the Vector Control 
Department of the Ministry of Health; 10% of blood slides 
were also read again by a different technician in CDLs 
Laboratories at UVRI and all results were consistent with 
the initial results.
Medical history was taken to capture a record of illnesses 
including previous (past 12 months) malaria episodes and the 
antimalarial medications received (artesunate containing regi-
mens have anthelminthic effects on S.mansoni), pneumonia 
episodes, convulsions, term at birth, number of times they 
received albendazole, and praziquantel, using a questionnaire 
that was developed for this sub-study (a copy is attached as 
Extended data)31. The questionnaire was administered to the 
parents (or guardians) of the children by three trained inter-
viewers at the study site (in each village). In addition, we 
collected information on the sanitation and hygiene within 
the household including details on whether the household 
owned their own latrine or used a public latrine, footwear, 
washing hands with soap, drinking unboiled water, use of bed 
nets and contact with lake water. We also collected family 
socio-demographic indicators including the materials with 
which the house is made (walls, roof, floor); the number and 
size of rooms, the number of people living in the house, whether 
they have electricity, and the source of water used in the house-
hold. We also collected information on schooling status 
of the child using an interview administered to the parents or 
guardians of the children. Quality of parent-child interactions 
is believed to influence cognitive development32; on a separate 
visit scheduled within two weeks of the cognitive assessments, 
observations for the quality of cognitive stimulation in the 
home environment were conducted. This was done using 
the Home Observation for Measurement of the Environment 
(HOME) tools33. The HOME assesses the physical and social 
aspects of the environment in eight domains which are Learning 
materials, Language stimulation, Physical environment, Respon-
sivity, Academic stimulation, Modelling, Variety, and Accep-
tance. The domains consist of items that are observed or 
the caregiver interviewed about. Subscale scores are summed 
together to obtain a total score. We used the Early Childhood 
HOME (EC-HOME) and Middle Childhood HOME (MC-HOME) 
versions of the HOME tool. The EC-HOME used for children 
aged 5 years had previously been adapted and translated for 
Ugandan children in one of our previous projects. It was tested 
on a few participants and found to be appropriate for partici-
pants in this study34. The MC-HOME, used for children aged 
6–9 years, was also translated and its appropriateness for this 
population assessed using a sample of 15 children aged between 
6–9 years selected from the villages that did not participate 
in the first round of assessments. All the items in the MC-
HOME were found to be appropriate, and were used in the main 
assessments. HOME was only administered at one year.
Primary outcomes: Based on findings of previous studies, the 
primary objectives were growth (height for age z-scores and 
weight for age z-scores), and cognitive scores (executive 
functions) i.e. attention control, cognitive flexibility, working 
memory, inhibitory control, and planning. These were assessed 
using Counting Span, Picture Search, Card Sort Test, Digit 
Span Backwards, Tower of London, and Delay Inhibition Task 
as shown in Table 1. The tests were directly administered to 
participating children by three trained assessors(nurses) who 
were supervised by a senior developmental psychologist. The 
assessments were conducted in individual sessions in a quiet 
room that was set up at each site (village). These tests were 
previously adapted for Ugandan children aged 4–5 years35, 
but for this study they were extended (by including more diffi-
cult cues or adjusting the scoring) to cater for a wider age-group 
(5–9 years).




Mental flexibility Card Sorting Task37
Working memory Counting Span38
Working memory Digit Span Backwards39
Inhibitory control Delay Inhibition Task40







(modification of Block Design)43
Motor function Grooved Pegboard
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Secondary outcomes were performance on general cognitive 
ability, and fine motor function. These abilities may affect 
performance on measures of specific cognitive abilities and 
may be on the pathway between worm infection and cognitive 
impairment. The two functions were therefore included as 
secondary outcomes and assessed using Information Scale and 
Pattern Construction, and Pegboard, respectively. These tests 
were administered together with the rest of the measures 
listed above in the same setting and under the conditions, as 
described above. All outcomes were measured first after one 
year and then after two years from the start of the intervention. 
Recruited participants continued to receive their quarterly or 
annual treatment doses as per their trial arm.
In line with the second objective, potential mediators of 
cognitive effects of worms were investigated as follows:
Immunological parameters: Tumour necrosis factor alpha 
(TNF-α) and interleukins (IL-6, IL-10) were measured in 
blood samples using ELISA technique as follows. Plates were 
coated with 50ul per well of capture antibody diluted in coating 
buffer (sodium bicarbonate/sodium carbonate pH 9.6) at a 
1:250 dilution and incubated overnight at +4°C. The plates 
were washed three times with phosphate-buffered saline (PBS) 
- Tween (1X PBS + 0.05% Tween 20) (wash buffer) using 
an ELx405 micro plate washer and blocked using 150µl per 
well of 10% FBS in PBS + 0.05% Tween 20 for 2hrs at room 
temperature. Two-fold serial dilutions of standards up to 
seven standard points, starting at top standard concentration 
of 500pg/ml were prepared. These were later used to gener-
ate the standard curve. Plates were washed three times. 50µl of 
samples, standards and controls added to their respective wells 
and plates were incubated overnight at 4°C. The plates were 
washed five times, and then 50µl of detection mix (detection anti-
body and enzyme reagent at 1:250 dilutions each) was added to 
each well and the plates incubated for 1 hour at room tempera-
ture. Next, plates were washed seven times and developed for 
30 minutes in the dark with 50µl per well of substrate mix 
(equal volumes of substrate A and B). The reaction was stopped 
using 25µl of peroxidase stop solution per well diluted 1:5 
using distilled water. Absorbance was read at 450nm and 
correction at 570nm on a micro-plate reader and cytokine 
concentrations in pg/ml generated using the Gen 5 software. 
We used the ELx808™ Absorbance Microplate Reader from 
BioTek to read the ELISAs.
Iron concentration: Haemoglobin was measured as a crude 
estimate of iron status in the blood using an Hb Heamocue 
201, but a more accurate estimation i.e. ferritin and transfer-
rin receptor in plasma levels were also determined. Plasma and 
serum levels of soluble transferrin receptor and ferritin were 
measured using the Cobas Intergra 400 plus (Roche Diagnos-
tics Ltd, Switzerland), an immunological technique utilising 
soluble transferrin receptor cassette and following the Cobas 
400/700/800, method manual 4th edition (Feb, 2008). Relation-
ships between these parameters and worm infections, treatment 
and cognitive performance were examined.
Statistical methods
Sample size calculation. Sample size and power were calculated 
based on the hypothesis that, after two years of intervention, 
intensive treatment would increase the mean height and 
weight and cognitive scores compared to standard treatment, 
by the amounts shown in Table 2 for the respective measures. 
With 26 clusters, a random sample of 20 children was 
required from each cluster to obtain sufficient power to detect 
meaningful differences at the 5% significance level and allow-
ing for a design effect of 2. An extra four children were added 
to each village (bringing the total to 24 children from each 
village) to cater for an anticipated loss to follow up of 15–20%, 
hence 624 children were targeted from the 26 villages in the 
LaVIISWA trial. In the event, as described above, it was not 
possible to sample from all villages at one year (12 villages 
had already started receiving the second year of treatment, two 
villages did not have children of eligible age), hence power 
to detect differences in the one year outcomes was lower than 
anticipated.
Data analysis. Data were entered in Microsoft Access and 
analysed in STATA version 15.0 (StataCorp, College Station, 
TX). Means and standard deviations were used to describe con-
tinuous data whereas percentages and proportions were used 
to describe categorical data. Correlations between outcomes 
were explored to examine collinearity. Raw height and weight 
data were converted into height for age z-scores (HAZ) 
and weight for age z-score (WAZ), respectively, and these were 
used for analysis of effects of treatment and other exposures. 
At both time points (year one and year two), cross-sectional 
comparisons of worm status, growth and cognitive performance 
were conducted between the two treatment arms. Analyses 
were done at the individual level, but allowed for the clustering 
Table 2. Sample size and power justification.






Picture Search 84% 0.7 2 1.4
Counting Span 80% 1 2 2.1
Height (adjusted for age) 99% 5 cm 2 6.7
Weight (adjusted for age) 87% 1.1 kg 2 2.1
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of participants within villages (clusters). Mean differences in 
HAZ, WAZ and cognitive scores on individual measures were 
compared, and using adjusted linear regression to allow for 
clustering (and adjusting for age and sex), the effect of 
treatment regimen was examined. To avoid the effect of col-
linearity, each outcome was examined separately. Within each 
arm, the same outcomes were examined for changes between 
the first and second time point of assessment using linear mixed 
effects models to account for the correlation of outcomes from 
the same individuals (at both time points) while adjusting for 
age, sex and clustering of children within villages. The effect of 
the intervention on changes between the first and second year 
was examined by fitting contrasts in the mixed effects models. 
Cytokine concentrations were not normally distributed, and 
hence were log transformed. Because of the multiple compari-
sons, a stringent p-value cut off of 0.01 was used to determine 
statistical significance for all analyses.
Results
Participants’ characteristics
After the first year, a total of 419 children within the age 
range of 5–9 years were identified from the village treatment 
registers of 12 villages (excluding two villages that did not 
have children in the right age bracket) and traced to their 
homes. Numbers varied with village size and also whether it 
was school time or holiday; enrolment was higher in larger vil-
lages than smaller ones and during holidays than school-term 
time. In eight of the 12 villages, the lists generated more 
than 24 children in the age group, and for these random sam-
pling was applied. However, in all the villages the number of 
children that were actually present was less than the target 
sample size. Hence the random selection was repeated until 
everyone in the lists was visited for availability. Altogether 
149 participants (intensive=85; standard=64) from 12 villages 
(intensive=7, standard=5) were eligible and available to par-
ticipate and were hence enrolled for the first round of cogni-
tive assessments. 270 children were not recruited because they 
were away either on the mainland for school (n=95), the fam-
ily had left the village and moved to the mainland (n=67), 
parents (and child) were away farming (n=25), parents declined 
to participate (n=5), children were over age (n=16), under age 
(n=1), not native Luganda speakers (n=1), had severe learn-
ing disability (n=3) or had died (n=2). Two children were 
excluded because they had moved to the islands for only two 
months and had not received any dose of mass treatment. The 
remaining 55 participants could not be found and there was no 
information about them.
After the second year, all 26 clusters (13 in each arm) were 
included and altogether 286 participants were assessed (inten-
sive=158; standard=128). These included 87 of the 149 participants 
who were assessed at one year and 199 who were recruited 
from 11 additional villages (the 12th additional village had no 
children aged 5–9 years). A total of 62 participants tested at the 
first assessment were not available for the second assessment 
mainly because they were away on the mainland for school. 
340 children were identified from the 11 additional villages. 
Of these, 141 were not recruited for reasons similar to those 
found after one year in the first block of villages i.e. migrated 
(n=73), on mainland for schooling (n=28), over age (n=29), 
parents not at home (n=5), parents refused to participate 
(n=4), language barrier (n=1), and one child had died. The 
breakdown of participants recruited and excluded is shown in 
the flow diagram (Figure 2), and the CONSORT flow diagram 
for the main study within which this project was nested has 
been previously published29. Participant characteristics in the 
two treatment arms were compared and found to be similar in 
all features except sex and age. Participants in the standard arm 
were slightly older, and there were more males than in the inten-
sive arm in the first year and less in the second year (Table 3); 
therefore, age and sex together with clustering were adjusted for 
in subsequent analyses.
Effects of the intervention on worm prevalence, growth 
and cognitive performance
Data from the first year showed a lower prevalence of 
Schistosoma mansoni in the intensive arm (41%) than in the 
standard arm (70%); aOR= 0.24; p<0.001; 95% CI: 0.12, 
0.49; Table 4). Similarly, the prevalence of Trichuris, hook-
worm and Ascaris was lower in the intensive than standard 
arm: the difference was statistically significant for Trichuris 
(17% in intensive versus 35% in standard; aOR=0.31; p=0.002; 
95% CI: 0.14, 0.66).
There were no significant differences in growth outcomes 
(HAZ and WAZ) between the two arms after the first year 
of the intervention (Table 4). Participants in the intensive arm 
had a somewhat higher mean score on the Delay Inhibition 
Task than those in the standard arm (mean difference=1.34; 
p=0.04; 95% CI: 0.06, 2.21) after the first year of the interven-
tion. For the remaining cognitive measures, the differences 
between the intensive and standard group were not statistically 
significant (Table 4).
Similar analyses were conducted for data collected after 
two years of the intervention. Results showed lower worm 
prevalence in the intensive arm than in the standard arm for 
both S. mansoni and Trichuris (Table 4) but no significant dif-
ferences in growth and cognitive outcomes between the two 
treatment arms (p>0.01) (Table 4).
Longitudinal effects of the intervention
We further examined the data for changes in worm infection, 
growth and cognitive performance between the first and second 
time points for each arm (longitudinal analysis) in an analy-
sis restricted to the 87 participants (intensive n=57; stan-
dard n=30) who had data at both time points (year one and 
year two). Prevalence of Trichuris increased in both arms, 
from 19% in the first year to 32% in the second year (inten-
sive arm); and from 51% to 57% (standard arm). The preva-
lence of schistosomiasis remained similar between the two time 
points in both treatment arms i.e. 43% and 47% in intensive 
arm, and 72% and 67% in the standard arm. There were slight 
increases in the HAZ and WAZ in the standard arm which were 
not statistically significant (Table 5). There were improvements 
in performance in three measures of cognitive function 
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Figure 2. Participant recruitment.
Table 3. Participants’ characteristics in each arm at the first year and second year.
1st year 2nd year
Int N= 85 Std N=64 Int N= 158 Std N= 128
Mean child-age (months, s.d) 90.13 (16.82) 92.16 (12.15) 84.39 (17.64) 86.5 (17.04)
Sex (males) 43% 57% 50% 44%
Mothers’ education (primary) 77% 82% 62% 61%
Fathers’ education (primary) 68% 71% 39% 45%
Children attending school 92% 92% 92% 90%
Mothers’ occupation (farming) 25% 30% 33% 37%
Fathers’ occupation (fishing) 51% 50% 58% 49%
Mean HOME score (s.d)a 28 (6.40) 31 (4.60)
Int = intensive treatment arm; Std = standard treatment arm; s.d = standard deviation; HOME = Home 
Observation for Measurement of the Environment.
aHOME assessments conducted only at year one.
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Table 4. Worm infection, growth and cognitive outcomes after one year, and 
after two years of the intervention.
Test Mean test score #Coef/ 
#aOR
95% CI P






*S. mansoni 41% 70% 0.24 0.12, 0.49 <0.001
*Trichuris 17% 35% 0.31 0.14, 0.66 0.002
*Hookworm 3% 5% 0.33 0.06, 1.76 0.20
*Ascaris 0% 8% - - -
Weight (WAZ) -.84 -.78 -.08 -0.36, 0.21 0.50
Height (HAZ) -.92 -.62 -.32 -0.63, -0.008 0.05
Picture Search 4.71 5.65 -0.54 -2.23, 1.15 0.50
Card Sort Test 5.14 5.28 0.17 -1.08, 1.37 0.88
Counting Span 5.31 5.70 -0.30 -0.94, 0.34 0.53
Digit Span Backwards 2.17 2.47 -0.22 -0.94, 0.48 0.42
Delay Inhibition Task 9.85 8.78 1.34 0.06, 2.21 0.04
Tower of London 6.95 6.42 0.65 -0.61, 1.91 0.59
Information Scale 22.61 19.26 3.87 1.33, 6.40 0.17
Pattern Construction 4.76 5.07 -0.16 -1.17, 0.84 0.78
Grooved Peg Board 3.66 3.78 -0.11 -0.72, 0.50 0.28






*S. mansoni 39% 69% 0.27 0.16, 0.43 <0.001
*Trichuris 17% 39% 0.31 0.18, 0.54 <0.001
*Hookworm 0% 0.78% - - -
*Ascaris 0% 3.1% - - -
Weight (WAZ) -.90 -.75 -.15 -0.40, 0.09 0.21
Height (HAZ) -.86 -.73 -.13 -0.38, 0.11 0.28
Picture Search 4.4 4.1 0.35 -0.05, 0.77 0.09
Card Sort Test 5.3 5.1 0.29 -0.45, 1.03 0.42
Counting Span 5.1 5.1 0.08 -0.58, 0.74 0.81
Digit Span Backwards 2.1 2.0 0.05 -0.60, 0.69 0.89
Delay Inhibition Task 9.1 9.2 0.12 -0.59, 0.82 0.73
Tower of London 7.3 7.2 0.18 -1.08, 1.44 0.77
Information Scale 25.5 26.1 0.33 2.30, 2.96 0.80
Pattern Construction 4.3 4.4 0.13 -0.88, 1.14 0.79
Grooved Pegboard 4.7 5.0 -0.27 -1.20, 0.67 0.56
Int = intensive arm; Std = standard arm; aOR=adjusted odds ratio; HAZ = height for age z-scores; 
WAZ = weight for age z-scores.
*Odds ratios were used for worm comparisons.
# Adjusted for age, sex and clustering.
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(Delay Inhibition, Information Scale, and Tower of London) 
and in a measure of motor function (Pegboard) in both arms. 
These are shown in Table 5.
We assessed whether these changes over time differed by 
intervention arm (Table 6). Among the growth outcomes, 
there were no significant differences in the growth parameters 
Table 6. Differences in outcomes between treatment arms after one 







       (Intensive vs Standard) 1 -0.04 -0.52,0.61 0.874
       (Intensive vs Standard) 2 -0.33 -0.15, 0.82 0.174
Information scale
       (Intensive vs Standard) 1 3.22 -0.24, 6.69 0.069
       (Intensive vs Standard) 2 -0.66 -4.13, 2.82 0.711
Delay Inhibition task
       (Intensive vs Standard) 1 2.70 1.19, 4.21 <0.001
       (Intensive vs Standard) 2 0.02 -1.45, 1.49 0.979
WAZ = weight for age z-scores; CI, confidence intervals
Table 5. Worm infection, growth and cognitive performance at one 
year and at two years of the intervention among children with 
data from both time points.
Outcome measure Intensive (N= 57) Standard (N= 30)
R1 R2 P* R1 R2 P*
S. mansoni 43% 47% 0.13 72% 67% 0.17
Trichuris 19% 32% 0.50 51% 57% 0.68
Weight (WAZ) -0.86 -0.92 0.71 -0.82 -0.58 0.13
Height (HAZ) -1.08 -1.07 0.92 -.72 -0.61 0.57
Picture Search 4.7 4.6 0.92 4.9 4.2 0.16
Card Sort Test 5.1 5.4 0.58 5.3 5.6 0.57
Counting Span 5.1 5.2 0.75 5.1 5.3 0.45
Digit Span Backwards 2.4 2.3 0.37 2.5 2.2 0.30
Delay Inhibition Task 9.6 9.3 0.53 7.4 9.5 0.01
Tower of London 6.3 7.9 0.004 6.0 8.7 0.001
Information Scale 21.0 26.6 <0.001 20.2 26.2 <0.001
Pattern Construction 4.6 5.0 0.39 5.3 6.4 0.11
Grooved Pegboard 3.5 5.5 <0.001 4.3 5.9 <0.001
R1 = after one year of the intervention; R2 = after two years of the intervention; HAZ 
= height for age z-scores; WAZ = weight for age z-scores.
* P-value for the difference among children within each treatment arm.
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between the treatment arms. Only two measures of cognitive 
function (i.e. Information Scale and Delay Inhibition task) 
showed significant differences in change from year one to year 
two between the two trial arms, with both showing greater 
improvement in the standard arm compared to the intervention 
arm (interaction term p-values = 0.015 and 0.004 for Information 
Scale and Delay Inhibition task, respectively) (Figure 3).
In line with our second objective, we assessed the associa-
tion of iron, and immunological cytokines (IL 6, IL 10 and 
TNF-α) with worm infection, treatment and cognitive perfor-
mance using regression analysis adjusting for age, sex and 
clustering. None of the associations were significant (p>0.01). 
These results are shown in Tables S1–S9 (see Extended data)44.
Discussion
This study examined growth and cognitive benefits of treat-
ing children for worms intensively (compared with standard 
treatment) and explored pathways hypothesized to be involved 
in cognitive effects of worms. There was greater reduction 
in worm burden in the intensive treatment arm than in the 
standard arm, but there was no significant difference between 
the treatment arms in growth, cognitive outcomes, or in 
measured potential mediators of effects of worms on cognition, 
at the end of one year or two years of the interventions.
The cluster randomised controlled mass treatment trial used 
in this study was a robust design for the rigorous measure-
ment of treatment effects in this highly endemic population. 
By the design, the intensive arm had a higher frequency of 
treatment and number of dosages of albendazole given at 
each treatment period than the standard arm. The intensive 
treatment was therefore expected to have a higher efficacy 
with regards to clearing worm infection. Lack of baseline 
data meant that we could not confirm that the trial arms were 
similar at baseline with regard to the primary outcome mea-
sures. The LaVIISWA trial, within which this work was nested, 
showed good baseline comparability between trial arms for 
relevant characteristics including markers of socio-economic 
status and occupation, as well as overall helminth infection 
prevalence11. However, in the age-group of interest (5–9 year 
olds) baseline prevalence of S. mansoni was 70% and 50% 
among villages allocated to standard and intensive treatment, 
respectively, implying that the different treatment regimens may 
not have been fully responsible for the differences in observed 
prevalence at one and two years in this sub-study.
While quarterly treatment may have reduced the worm bur-
den compared to annual treatment in the first year of the 
intervention, further treatment did not further reduce worm 
infection prevalence in the second year in either trial arm and 
Figure 3. Average values for weight, Information Scale and Delay Inhibition Task between the two arms across the two time 
points.
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there was no increase in divergence between the trial arms. 
At baseline of the main trial, the distribution of infection 
prevalence for both S. mansoni and Trichuris peaked in the 
10–15 age group in this community11. Among the subgroup 
of children followed from year one to year two of the inter-
vention, age increased by one year towards the peak preva-
lence age group, but helminth prevalence (particularly for 
schistosomiasis) did not increase, implying some element of 
infection control. Kato Katz stool analyses (used to assess 
helminth infection status in this study) under-estimate infec-
tion prevalence: in the LaVIISWA trial as a whole, intensive 
treatment was shown to reduce intensity of S. mansoni infec-
tion as assessed by Kato Katz analysis, but almost all com-
munity members were found to remain positive on the more 
sensitive urine circulating cathodic antigen test29. Communities 
(including children) in these islands are constantly exposed to 
schistosomiasis and soil transmitted worms. They bathe, wash, 
fetch water, play and swim in the lake water, which is heav-
ily infested with schistosomiasis11,29. Poor hygiene including 
lack of footwear and lack of toilets, and open disposal 
of human waste, which is washed back into the lake, is a 
widespread characteristic of the community. Given these 
circumstances, it is almost impossible to clear or control 
worm infection with treatment alone. Additional strategies 
including health education, improved sanitation and hygiene 
(handwashing, footwear, using toilets) would be needed to 
achieve greater worm clearance in these communities.
In this context, intensive treatment of worms did not have 
significant impact on growth or cognitive outcomes. This 
could mean that a partial reduction in worm burden is not 
sufficient to improve growth or cognitive function. Based on 
the mean height and weight z-scores at the initial follow up, 
children in both treatment arms had sub-optimal growth for 
age. Within the sub-group followed from year one to year two, 
there were no significant increases in growth measures, and 
only borderline improvements in cognitive scores, between 
the first and second year within each arm. There were no dif-
ferences in the changes between the trial arms. Similar find-
ings were reported in a previous study where treatment for 
Schistosoma japonicum had short term improvements in 
cognitive function but did not have long term effects7. The 
WHO recommended dose for praziquantel is currently 
40mg/kg including for children. Recent studies have shown 
that in school-aged children, a higher dose of praziquantel 
(60mg/kg) has higher efficacy (83%) than the 40mg/kg dose 
(69%)45; however, in the context of high transmission and rein-
fection rates, treatment alone may not fully clear the infec-
tion. It was not possible to use a different treatment regimen 
since our study was nested within the design of the bigger trial 
(LaVIISWA). Future studies could investigate whether effective 
treatment, combined with interventions to prevent re-infection 
over longer durations of follow up, can result in significant 
improvements in growth and cognition.
This sub-study had some limitations; we used a 
cluster-randomised design in which the villages (clusters) were 
randomised; however, not all the children that participated 
in the study were randomly selected; random sampling was 
only applied when there was a potential candidate pool of more 
than 24 children in a particular cluster (village). Seventy-one 
children from three villages were randomly selected. This 
method introduces potential bias to the study design.
Based on our power calculation, we aimed to recruit 24 par-
ticipants from each cluster, and hoped to have a study 
population of 624. However, in the first round, 12 villages could 
not be included and two villages did not have children of the 
required age group. In some of the villages there were fewer 
numbers of eligible children. We achieved an enrolment of 
149 for the one year follow up and 286 at the two-year 
follow-up. The target sample size was not achieved and study 
therefore was underpowered. This could have contributed to 
the lack of significant differences between the two arms.
Worms have lived with us for a long time. Studies of immuno-
logical and allergic outcomes of worms have indicated a protec-
tive effect of worms against allergy-related disease in humans46, 
highlighting the evolutionary adaptations that have occurred. 
Although parasitic worm infections undoubtedly cause pathol-
ogy, it is possible that worms and humans have mutually 
adapted to a greater extent than is generally recognised, such 
that, in the majority of infected individuals, and in the context 
of adequate nutrition, key biological functions such as neuro-
cognitive development are spared. It is possible that parasitic 
worms do not inherently impair developmental outcomes of 
children in worm endemic settings.
Data availability
Underlying data
LSHTM Data Compass: LaVIISWA Round 1 and 2 Dataset. 
https://doi.org/10.17037/DATA.0000180231
This project contains the following underlying data:
-      round1and2_merged_OA_dataset.xlsx (Anonymised 
dataset containing measurements collected during first 
and second data collection rounds in XLSX format)
-      round1and2_merged_OA_dataset.csv (Anonymised 
dataset containing measurements collected during first 
and second data collection rounds in XLSX format)
-      LaVIISWA_Round1-and-2_codebook-v2.html (Codebook 
for de-identified and full dataset)
Extended data
LSHTM Data Compass: Effect of intensive versus stan-
dard anthelminthic treatment on growth and cognition among 
children living in a high Schistosoma mansoni transmission 
setting - Supporting Information. https://doi.org/10.17037/DATA. 
0000189544
This project contains the following extended data:
-      Cognitive_Function_Cohort_Table_s1.docx (Table S1. 
Descriptive summary for the cytokines at one year)
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-      Cognitive_Function_Cohort_Table_s2.docx (Table S2. 
Association between worm infection and cytokine 
concentration at one year)
-      Cognitive_Function_Cohort_Table_s3.docx (Table S3. 
The effect of treatment on cytokine concentration)
-      Cognitive_Function_Cohort_Table_s4.docx (Table S4. 
Associations between TNF- alpha concentrations (log 10) 
and motor and cognitive scores)
-      Cognitive_Function_Cohort_Table_s5.docx (Table S5. 
Associations between IL-6 concentrations (log10) and 
motor and cognitive scores)
-      Cognitive_Function_Cohort_Table_s6.docx (Table S6. 
Associations between IL-10 concentrations(log10) and 
motor and cognitive scores)
-      Cognitive_Function_Cohort_Table_s7.docx (Table S7. 
Association between worm infection and treatment with 
iron measured using Ferritin and transferrin)
-      Cognitive_Function_Cohort_Table_s8.docx (Table S8. 
Association between serum ferritin and cognitive 
outcomes)
-      Cognitive_Function_Cohort_Table_s9.docx (Table S9. 
Association between soluble transferrin receptor and 
cognitive outcomes)
LSHTM Data Compass: LaVIISWA Round 1 and 2 Dataset. 
https://doi.org/10.17037/DATA.0000180231
This project contains the following extended data:
-      LaVIISWA_questionnaire.pdf (Socioeconomic and 
medical information questionnaire)
-      CFC_Scoring_Sheet_Cognitive_Tests.pdf (Scoring sheet 
for cognitive tests)
Data are available under the terms of the Creative Commons 
Attribution 4.0 International license (CC-BY 4.0).
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